{"count": 1, "results": [{"_id": "36519659", "pmid": 36519659, "title": "Use of metformin in patients who require intravascular administration of a contrast agent.", "journal": "Endokrynol Pol", "authors": ["Rokicka D", "Wróbel M", "Stołtny D", "Strojek K"], "date": "2022-01-01T00:00:00Z", "doi": "10.5603/EP.a2022.0079", "meta_date_publication": "2022", "meta_volume": "73", "meta_issue": "6", "meta_pages": "913-916", "score": 50264.953, "text_hl": "Due to its properties, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ is used in the treatment of @<m>DISEASE_Glucose_Galactose_Malabsorption</m> @DISEASE_MESH:C562602 @@@carbohydrate disorders@@@ (in @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@, @DISEASE_Prediabetic_State @DISEASE_MESH:D011236 @@@prediabetes@@@) and in @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@insulin resistance syndromes@@@ (including @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@polycystic ovary syndrome@@@). ", "citations": {"NLM": "Rokicka D, Wróbel M, Stołtny D, Strojek K. Use of metformin in patients who require intravascular administration of a contrast agent. Endokrynol Pol. 2022;73(6):913-916. PMID: 36519659", "BibTeX": "@article{36519659, title={Use of metformin in patients who require intravascular administration of a contrast agent.}, author={Rokicka D and Wróbel M and Stołtny D and Strojek K}, journal={Endokrynol Pol}, volume={73}, number={6}, pages={913-916}}"}}]}